Author: Joe Martin, PBC Communications
-
UArizona Health Sciences previews new Center for Advanced Molecular and Immunological Therapies in Phoenix
The University of Arizona offered a new preview of the Center for Advanced Molecular and Immunological Therapies on May 16 as part of its Tomorrow is Here lecture series. The […]
-
Slideshow: Wexford Science + Technology plans new innovation labs at 850 PBC
Wexford Science & Technology, LLC, a national innovation district developer that partners exclusively with universities, academic medical centers, and research institutions, is launching the Wexford Innovation Labs at 850 PBC, the firm’s newest development located in the Phoenix Bioscience Core.
-
ASU names Marisa Domino to lead Center for Health Information and Research
ASU announced Marisa Domino will lead the Center for Health Information and Research in ASU’s College of Health Solutions on the downtown Phoenix campus.
-
Arizona Medical Association welcomes Dr. Jennifer Hartmark-Hill as 131st President
-
TGen begins testing animals in captivity and nature for COVID-19
Working with state and federal wildlife agencies and private and public zoos across Arizona, the Translational Genomics Research Institute (TGen), part of City of Hope, is testing wild animals in captivity and in nature for SARS-CoV-2, the pathogen that causes COVID-19 in humans.
-
Bioscience leaders connect the dots between the arts and biosciences
On March 3, Artlink and Phoenix Community Alliance’s Arts, Culture & Public Life Committee hosted the 6th Annual Creative City Symposium. The virtual event, attended by 65 local arts advocates and community leaders, served up a multi-faceted conversation about the state of the arts and the role that creativity and the arts play in a…
-
UArizona College of Medicine – Phoenix’s Ayman Fanous contributes to largest worldwide study of Schizophrenia
In a paper published April 8 in Nature, specific genes were identified that could play important roles in the psychiatric disorder. In the largest genetic study of schizophrenia, researchers including Ayman Fanous, MD, analyzed DNA from 76,755 people with schizophrenia and 243,649 without it to better understand the genes and biological processes underpinning the condition.
-
Calviri announces new scientific advisory board
The newly formed Scientific Advisory Board will collaborate closely with Calviri’s senior leadership team and support the advancement of the company’s diversified portfolio of diagnostic platforms and therapeutic cancer vaccines pipeline targeting both human and animal health.
-
Catheter-based cardioneural ablation safe, effective for recurrent fainting, according to UArizona COM-P report
e by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.
-
Connecting with UArizona College of Medicine – Phoenix Dean Guy Reed
The University of Arizona Health Sciences spoke to UArizona College of Medicine – Phoenix Dean Guy Reed at the end of the academic year to discuss the past two years, what lies ahead for the College of Medicine – Phoenix and the Phoenix Bioscience Core.
